Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEE, M. C.
Right arrow Articles by LOEWENSON, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEE, M. C.
Right arrow Articles by LOEWENSON, R. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE

(Stroke. 1974;5:216.)
© 1974 American Heart Association, Inc.


Ineffectiveness of Dexamethasone for Treatment of Experimental Cerebral Infarction

MYOUNG C. LEE M.D.1; ANGELINE R. MASTRI M.D.1; ARTHUR G. WALTZ M.D.1; RUTH B. LOEWENSON PH.D.1

1 Cerebrovascular Clinical Research Center, Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455

Ischemic cerebral edema occurring with cerebral infarction may cause increases of intracranial pressure and neurological deficits or death. Certain other types of cerebral edema are influenced by adrenal glucocorticoids; there is conflicting evidence about effects on ischemic edema, largely due to differences in experimental models and dosages. Therefore, dexamethasone in large doses was studied in 15 cats with experimental cerebral ischemia and infarction produced by transorbital occlusion of one middle cerebral artery (MCA). Five cats received dexamethasone, 4 mg per kilogram intramuscularly, twice daily for two weeks before and two weeks after MCA occlusion; five received dexamethasone for two weeks after occlusion; and five received no dexamethasone. There were no apparent differences among the three groups in the neurological deficits resulting from MCA occlusion, and no statistically significant differences in the sizes of cerebral infarcts. Dexamethasone is ineffective for the treatment of experimental cerebral ischemia produced by MCA occlusion.


Key Words: cerebral edema • cerebral ischemia • middle cerebral artery occlusion




This article has been cited by other articles:


Home page
PediatricsHome page
R. C. Vannucci and J. M. Perlman
Interventions for Perinatal Hypoxic-Ischemic Encephalopathy
Pediatrics, December 1, 1997; 100(6): 1004 - 1114.
[Full Text] [PDF]